Showing 8,921 - 8,940 results of 29,970 for search '(( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 5 step decrease ))', query time: 1.05s Refine Results
  1. 8921

    <i>A</i>ltered gene expression profiles in the median and pectoral fin of <i>Tg(Inta11:NTR)</i> larvae following metronidazole treatment. by Robert L. Lalonde (4840260)

    Published 2018
    “…Inta11: NTR + MTZ show a decrease in distal <i>hoxa13a</i> expression (red arrow) in the median fin at 60hpf (B), and in the pectoral fin at 72hpf (D) compared to Inta11: NTR—MTZ (green arrow) (A, C). …”
  2. 8922

    Forty years of a psychiatric day hospital by Rosário Curral (12854125)

    Published 2022
    “…In the subsequent years, this proportion decreased, and the number of admissions for schizophrenia (C) exceeded 50% in 2004- 2009. …”
  3. 8923
  4. 8924
  5. 8925
  6. 8926

    Actions to Include in a Farm Environment Plan by Annabel McAleer (15329209)

    Published 2024
    “…This interactive infographic is a compilation of actions to decrease the loss of contaminants from agricultural land. …”
  7. 8927

    Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio by Julian Laux (13047767)

    Published 2023
    “…., tofacitinib, 0.2–0.4 μmol/kg bid) in clinical use, suggesting an efficient underlying mode of action. We hypothesized that their effectiveness is due to their ability to raise the ratio of IL-10 to TNFα. …”
  8. 8928
  9. 8929
  10. 8930
  11. 8931

    Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

    Published 2025
    “…The IC<sub>50</sub> value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”
  12. 8932

    Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

    Published 2025
    “…The IC<sub>50</sub> value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”
  13. 8933

    Effects of Common Polymorphisms rs11614913 in <em>miR-196a2</em> and rs2910164 in <em>miR-146a</em> on Cancer Susceptibility: A Meta-Analysis by Wei Xu (28953)

    Published 2011
    “…Rs11614913 in <em>miR-196a2</em> and rs2910164 in <em>miR-146a</em> are shown to associate with increased/decreased cancer risk. …”
  14. 8934

    MiR-29a targets PTEN. by Guangyao Kong (185282)

    Published 2011
    “…Empty pcDNA3.0 plasmid (200 ng) was used as a negative control. (C) Luciferase reporter gene assay showed that the decreased luciferase activities of PTEN 3′UTR reporter (PTEN 3′UTR-1 or PTEN 3′UTR-2) in HepG2 cells mediated by miR-29a overexpression (200 ng) was rescued by a miR-29a inhibitor in a dose dependent manner (30, 50, and 100 nM). …”
  15. 8935

    Modulation of Aβ-induced deleterious signaling. by Tao Yang (184280)

    Published 2008
    “…<p>For each study, LM11A-24 and -31 were present at 100 nM and NGF at 50 or 100 ng/ml. …”
  16. 8936

    Effects of sialidase treatment on substantia nigra dopamine neurons. by Jay S. Schneider (671374)

    Published 2015
    “…<p>Sub-acute MPTP treatment (aCSF-MPTP) resulted in significant decreases in the number of tyrosine hydroxylase immunopositive (A.) and Nissl-stained (B.) cells in the substantia nigra pars compacta. …”
  17. 8937

    Data selection by changes in the firing rate. by Huu Hoang (9188747)

    Published 2020
    “…<p>A: the histograms of firing rate change by drug treatments (decreased by CBX and increased by PIX) compared to the CON condition. …”
  18. 8938

    Identity between upstream stripes and Alu-sequences and their expression as a function of upstream poly(A)-segments of the GA-sequences. by Guenter Albrecht-Buehler (266704)

    Published 2009
    “…<p>The GPxIs show portions of the GA-complexes of human chr.1 after sorting them by the decreasing size of poly(A)-segments at the upstream end of the GA-sequences. …”
  19. 8939

    CORT triggered a slow-onset increase in GluN2A/GluN2B ratio. by Yiu Chung Tse (340737)

    Published 2013
    “…<p>(<b>A</b>) Plots of NMDAR-EPSC amplitude from control and CORT-treated slices against time show decreased EPSC amplitude after sequential application of Ro (1 µM; for 30 min) and a mixture of Ro and a subunit non-selective NMDAR antagonist APV (50 µM; for 10 min). …”
  20. 8940